Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer
- Elez, E.
- Hendlisz, A.
- Delaunoit, T.
- Sastre, J.
- Cervantes, A.
- Varea, R.
- Chao, G.
- Wallin, J.
- Tabernero, J.
ISSN: 1532-1827, 0007-0920
Year of publication: 2016
Volume: 114
Issue: 4
Pages: 372-380
Type: Article